BeiGene, Ltd. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2016 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
BeiGene, Ltd. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2016 to Q3 2024.
  • BeiGene, Ltd. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 1.38B shares, a 0.98% decline year-over-year.
  • BeiGene, Ltd. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.36B shares, a 1.22% increase from 2022.
  • BeiGene, Ltd. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1.34B shares, a 11.2% increase from 2021.
  • BeiGene, Ltd. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 1.21B shares, a 11.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 1.38B -13.6M -0.98% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 1.36B +858K +0.06% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 1.36B +1.38M +0.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 1.36B +16.3M +1.22% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 1.39B +45M +3.35% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 1.36B +23.8M +1.78% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 1.35B +22.1M +1.66% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 1.34B +135M +11.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 1.35B +139M +11.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 1.34B +142M +11.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 1.33B +74.5M +5.93% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 1.21B +121M +11.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 1.21B +57M +4.96% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 1.19B +184M +18.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 1.26B +252M +25.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 1.09B Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 1.15B Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 1.01B Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 1.01B Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2018 740M +139M +23.2% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-08
Q3 2017 601M +172M +40.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q3 2016 428M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.